Dr. John Gamba
John F. Gamba-Rendon, MD, MPH
+1(630) 669-1817
terum_07@hotmail.com
Associate Director, Scientific Communications | Global Medical Affairs
PROFESSIONAL SUMMARY
Physician and public health professional (MD, MPH) with over 15 years of experience across Medical Affairs and Scientific Communications in global biopharmaceutical organizations. Proven ability to bridge medical strategy, scientific communication, and population health, translating clinical, real-world, and epidemiological evidence into education, engagement, and decision-making. Experienced in medical leadership roles spanning medical management, scientific platform development, congress strategy, governance and review committees, and health equity–focused initiatives. Recognized for cross-functional leadership, strategic judgment, and advancing responsible, evidence-based medical engagement. Particularly interested in applying pharma’s strategic and operational frameworks to global health, population health, and equity initiatives, moving beyond access to medicines toward sustainable improvements in patient outcomes.
CORE COMPETENCIES
- Global scientific communication strategy and platforms
- Publications and data dissemination strategy
- Medical education and congress leadership
- Evidence synthesis and data storytelling
- Medical governance (MLR / PRC)
- KOL engagement and advisory boards
- Medical training and capability building
- Health equity–informed scientific messaging
PROFESSIONAL EXPERIENCE
Associate Director, Global Scientific Communications
Takeda Pharmaceuticals, Cambridge MA | 2025 – Present
- Own global scientific communications strategy for pipeline immunology assets, ensuring alignment with medical strategy and long-term asset vision.
- Owned scientific platform development and governance for assigned assets, leading cross-functional alignment on core scientific statements, training internal teams on publications best practices, and contributing to development and review of publications SOPs and work practices.
- Led global publications and scientific communications strategy, developing and executing integrated publication plans in partnership with Medical Affairs, Clinical Development, HEOR/RWE, and global, regional, and affiliate teams to ensure alignment, compliance, and timely data dissemination.
- Directed end-to-end publication development including peer-reviewed manuscripts, congress abstracts and presentations, scientific slide decks, NCCN/pathway materials, digital data amplification, field medical tools, and training assets, ensuring scientific accuracy, rigor, and adherence to global standards.
- Served as primary publications lead and external liaison, managing investigator and author engagement, vendor and agency execution, publication timelines, and annual program budgets in accordance with Good Publication Practice (GPP) and internal SOPs.
Senior Medical Manager, Global Medical Communications
Takeda Pharmaceuticals, Cambridge MA | 2023 – 2025
- Own global scientific communications strategy for pipeline and marketed assets, including mezagitamab and maribavir, ensuring alignment with medical strategy and long-term asset vision.
- Led development and evolution of global scientific communication platforms, integrating clinical, epidemiological, and real-world evidence.
- Directed end-to-end congress strategy and execution, including content development, scientific booth strategy, insight capture, and post-congress synthesis.
- Serve as principal medical reviewer on Scientific MLR and Product Review Committees, providing governance oversight and strategic guidance.
- Design and deliver global scientific training programs for medical and commercial organizations, including leadership of international Science Day programs.
- Partner with global, regional, and affiliate medical teams to ensure consistent, compliant, and impactful scientific messaging.
Senior Medical Manager, Multiple Sclerosis Franchise
Biogen, Boston MA | 2019 – 2023
- Executed integrated medical communication tactics supporting global and affiliate medical strategies.
- Developed scientific content for advisory boards, medical education programs, and internal training.
- Ensured competitive readiness through development of scientific resources, repositories, and training materials.
- Served as medical lead for investigator-sponsored studies and sponsored research agreements.
- Contributed to global and regional congress planning, including abstract support and scientific engagement activities.
Medical Manager, Rare Diseases
Sanofi Genzyme, Colombia | 2014 – 2017
- Led medical education and scientific engagement for enzyme replacement therapies in rare diseases.
- Developed disease education programs and diagnostic initiatives to improve identification and management of rare disease patients.
- Built and maintained strong relationships with national and international key opinion leaders.